World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
21746
World Ranking
1908
National Ranking
931

Medicine

D-Index
76
Citations
21768
World Ranking
18765
National Ranking
9350

Overview

Gerd Ritter is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans biochemistry, genetics, molecular biology, and medicine, with a focus on molecular biology and subfields related to immunology, allergy, and oncology.

Their work emphasizes the study of specific biological processes such as TGF-β signaling in diseases, cell adhesion molecules, and cancer cell behavior including metastasis. These topics indicate a deep engagement with cellular signaling pathways and mechanisms involved in cancer progression and immune response modulation.

Ritter's recent publications include:

  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer, 2021, Communications Biology
  • 567 Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers, 2021, Regular and Young Investigator Award Abstracts

Their research contributions are documented in venues such as Communications Biology and Regular and Young Investigator Award Abstracts, illustrating participation in both peer-reviewed journals and conference abstracts.

Frequent collaborators in their research projects are:

  • Aditi Gupta
  • Sadna Budhu
  • Rachel Giese
  • Adam O. Michel
  • Aliya Holland

This network of coauthors suggests ongoing collaborative efforts across multiple studies, often involving investigations related to TGF-β signaling and cancer biology.

Best Publications

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy

  • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Sacha Gnjatic;Djordje Atanackovic;Elke Jäger;Mitsutoshi Matsuo

  • Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

    P O Livingston;G Y Wong;S Adluri;Y Tao

  • NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

    Ian F. Hermans;Jonathan D. Silk;Uzi Gileadi;Mariolina Salio

  • Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

    Elke Jäger;Sacha Gnjatic;Yasuhiro Nagata;Elisabeth Stockert

  • Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    E Jäger;Y Nagata;S Gnjatic;H Wada

  • NY-ESO-1: review of an immunogenic tumor antigen.

    Sacha Gnjatic;Hiroyoshi Nishikawa;Achim A Jungbluth;Ali O Güre

  • The crystal structure of human CD1d with and without alpha-galactosylceramide.

    Michael Koch;Victoria S Stronge;Dawn Shepherd;Stephan D Gadola

  • Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    Ali O. Gure;Ramon Chua;Barbara Williamson;Mithat Gonen

  • Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

    Elke Jäger;Dirk Jäger;Julia Karbach;Yao-Tseng Chen;Yao-Tseng Chen

  • Colon cancer associated transcript-1: A novel RNA expressed in malignant and pre-malignant human tissues

    Aviram Nissan;Alexander Stojadinovic;Stella Mitrani-Rosenbaum;David Halle

  • Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

    Paul Sabbatini;Takemasa Tsuji;Luis Ferran;Erika Ritter

  • Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

    Kunle Odunsi;Feng Qian;Junko Matsuzaki;Paulette Mhawech-Fauceglia

  • NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

    Kunle Odunsi;Achim A. Jungbluth;Elisabeth Stockert;Feng Qian

  • Structure of Human Cd1B with Bound Ligands at 2.3 A, a Maze for Alkyl Chains

    Stephan D. Gadola;Stephan D. Gadola;Nathan R. Zaccai;Karl Harlos;Dawn Shepherd

  • Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.

    Elke Jäger;Elisabeth Stockert;Zacharias Zidianakis;Yao-Tseng Chen;Yao-Tseng Chen

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.

    Matthew J. Scanlan;Sydney Welt;Claudia M. Gordon;Yao-Tseng Chen

  • Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases

    Daniel Phaneuf;Nobuaki Wakamatsu;Jing-Qi Huang;Anita Borowski

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    Michael Schmitt;Anita Schmitt;Markus T. Rojewski;Jinfei Chen

Frequent Co-Authors

Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Alexander Knuth
Alexander Knuth University of Zurich
Elke Jäger
Elke Jäger Goethe University Frankfurt
Hiroyoshi Nishikawa
Hiroyoshi Nishikawa Nagoya University
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Hiroshi Shiku
Hiroshi Shiku Mie University
Antony W. Burgess
Antony W. Burgess Walter and Eliza Hall Institute of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Programs such as Licensed Practical Nurse (LPN) degrees offer a foundational entry into the medical field. If you're seeking accessible options, look into the easy admission LPN programs which provide a streamlined path into nursing careers.

Advancing in nursing can lead to specialties like the Nurse Practitioner (NP) role. Some of the easiest NP programs to get into might be appealing if you want to pursue advanced practice nursing with minimal barriers to entry.

For those interested in mental health, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs offer specialized training. Choosing from the best online PMHNP programs ensures strong clinical placements, facilitating hands-on learning and smoother career transitions.

Cost is also a major factor. Thankfully, there are cheapest psych NP programs that combine quality education with affordability, making advanced nursing education more accessible to a wider audience. These pathways complement an immunology background, paving the way for impactful roles in healthcare and research.

Best Scientists Citing Gerd Ritter

Trending Scientists

Recently Published Articles